Inhibitors of angiotensin I converting enzyme for treating hypertension.
- 6 September 1980
- Vol. 281 (6241) , 630-631
- https://doi.org/10.1136/bmj.281.6241.630
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSIONThe Lancet, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.Hypertension, 1979
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- The Effect of the Converting Enzyme Inhibitor SQ 20.881 on Kinins, Renin‐Angiotensin‐Aldosterone and Catecholamines in Relation to Blood Pressure in Hypertensive PatientsActa Medica Scandinavica, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977